The import of Erythromycin into India is projected to increase steadily from 2024 through 2028. In 2023, actual imports stood at a slightly lower volume compared to forecasted data starting in 2024. The year-on-year growth rate shows a consistent increase each year, with a Compound Annual Growth Rate (CAGR) capturing the average growth trend over this five-year period. This indicates a stable rise in demand for Erythromycin imports.

Future trends to watch for:

Changes in global supply chain dynamics that may impact import volumes and costs.
Regulatory changes in India affecting pharmaceutical imports and consumption.
Innovations or substitutes in the antibiotics market which might influence Erythromycin demand.